Triprolidine hydrochloride monohydrate 属于第一代抗组胺试剂,是一种具有口服活性的组胺 H1 (histamine H1) 拮抗剂,可用于过敏性鼻炎的研究。在大鼠中, Triprolidine hydrochloride monohydrate 能阻滞脊髓运动和知觉。
| Target | Value |
H1 receptor
()
|
Triprolidine hydrochloride monohydrate (292.81-1467.20 μg/kg; intrathecal injection) produces a dose-dependent effect of spinal motor and sensory block in rats.
|
Animal Model:
|
Male Sprague-Dawley rat (300-350 g)
|
|
Dosage:
|
292.81 μg/kg, 488.02 μg/kg, 733.60μg/kg, 1098.83 μg/kg, 1467.20 μg/kg
|
|
Administration:
|
Intrathecal injection
|
|
Result:
|
Elicited a dose-dependent spinal block.
|